Today: 21 March 2026
Browse Category

Stock Market 14 January 2026

Vodafone share price nudges lower as buyback rolls on; UBS keeps Sell call on VOD.L

Vodafone share price nudges lower as buyback rolls on; UBS keeps Sell call on VOD.L

Vodafone shares fell 0.4% to 98.3 pence by 0932 GMT in London, after a 2.6% drop Tuesday, despite another buyback announcement. The company repurchased over 5.2 million shares on Jan. 13, adding to its treasury stock. Investors are awaiting Vodafone’s trading update on Feb. 5 for further direction. UBS maintained its “sell” rating but raised the target price to 82 pence.
South Korea delays first STO exchange licences as Lucentblock-Nextrade fight heats up

South Korea delays first STO exchange licences as Lucentblock-Nextrade fight heats up

South Korea’s Financial Services Commission delayed a decision on preliminary licenses for new over-the-counter marketplaces for tokenized securities at its Jan. 14 meeting. Lucentblock accused rival Nextrade of misusing confidential information, which Nextrade denied. The regulator was expected to pick up to two operators from three contenders. The delay leaves the selection unresolved and intensifies pressure on Lucentblock.
14 January 2026
Imperial Brands stock holds steady after fresh buyback disclosure; AGM and dividend dates loom

Imperial Brands stock holds steady after fresh buyback disclosure; AGM and dividend dates loom

Imperial Brands PLC repurchased 291,666 shares on Jan. 13 at an average price of 3,012.98 pence, canceling them to reduce shares outstanding to 793,362,213. Shares traded near 3,009 pence early Wednesday, little changed after the buyback news. The company’s annual meeting is set for Jan. 28, with a final dividend payment scheduled for March 31, pending approval.
14 January 2026
GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next

GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next

GSK shares rose about 0.4% in early London trading after Summit Therapeutics announced a clinical trial collaboration to test ivonescimab with GSK’s experimental B7-H3 cancer drug. Patient dosing is expected to begin in mid-2026. GSK will report full-year results on Feb. 4. Senior managers recently acquired small amounts of GSK shares through company plans.
Rio Tinto plc stock edges up as Glencore deal talk deepens with bank advisers lined up

Rio Tinto plc stock edges up as Glencore deal talk deepens with bank advisers lined up

Rio Tinto shares rose 0.3% to 6,231 pence after reports it hired JPMorgan, Evercore, and Macquarie to advise on a possible Glencore takeover. The potential deal could create a $200 billion mining group. Rio has until Feb. 5 to make a formal offer or withdraw, and said there’s no guarantee a bid will happen. BHP is not planning a rival bid, according to sources.
Reckitt Benckiser stock dips after RBC downgrade as a big cash-return vote closes in

Reckitt Benckiser stock dips after RBC downgrade as a big cash-return vote closes in

Reckitt shares fell nearly 0.8% in early London trading after RBC Capital Markets downgraded the stock to “sector perform” and cut its price target to 6,200 pence. The move comes ahead of a shareholder vote on a 235 pence special dividend and share consolidation set for January 27. Reckitt recently completed the sale of its Essential Home business and repurchased 48,340 shares on January 13. Full-year results are due March 5.
14 January 2026
Anglo American plc stock rises after Norges Bank nudges stake above 3% as copper, deal talk stay in focus

Anglo American plc stock rises after Norges Bank nudges stake above 3% as copper, deal talk stay in focus

Anglo American shares rose 0.7% to 3,242 pence in early London trading after Norges Bank disclosed raising its stake above 3%. The stock fluctuated between 3,234 and 3,264 pence by 0804 GMT. BHP is not preparing a bid as Rio Tinto and Glencore discuss a takeover, sources told Reuters. EU regulators set a Feb. 3 deadline for a simplified review of Anglo’s planned merger with Teck Resources.
Union Bank of India share price hits 5-year high after Q3 FY26 profit rises 9% and NPAs fall

Union Bank of India share price hits 5-year high after Q3 FY26 profit rises 9% and NPAs fall

Union Bank of India shares jumped nearly 8% to a five-year high after Q3 net profit rose 9% to 5,017 crore rupees and gross bad-loan ratio dropped to 3.06%. Net interest income increased 1% to 9,328 crore rupees. The Nifty PSU Bank index gained about 2% in afternoon trade. Bank of Maharashtra reported a 26.5% rise in quarterly profit on Tuesday.
LAMMA 2026 opens with New Holland’s UK debut, JCB’s Fastrac 6000 — and a stark farm safety display

LAMMA 2026 opens with New Holland’s UK debut, JCB’s Fastrac 6000 — and a stark farm safety display

New Holland, Deutz-Fahr, Fendt, and JCB launched new high-horsepower tractors at LAMMA 2026 in Birmingham on Wednesday. NAAC prepared a memorial display for 28 farming accident fatalities since April 2025. Visitors can buy half-price tickets to the Agronomy Exchange conference in London this February. The event runs Jan. 14-15 at the National Exhibition Centre.

Stock Market Today

  • Americas Gold and Silver (TSX:USA) May Offer Value Despite Recent Pullback
    March 21, 2026, 6:20 AM EDT. Americas Gold and Silver shares have gained 260% over the past year but dropped nearly 27% in the last week. The sharp pullback follows a strong multi-year rally, prompting debate over whether valuations remain justified. A discounted cash flow (DCF) analysis indicates the stock could be undervalued by 62.5%, with an intrinsic value estimate of $19.68 versus the current price near $7.38. The company reported a recent free cash flow loss but forecasts positive cash flow through 2029. Price-to-sales ratios also provide insight amid volatile earnings typical in mining. Investors are weighing current share price against the firm's fundamentals and balance sheet as they assess potential upside amid industry volatility.
Go toTop